Important safety considerations include: Diabetic retinopathy complications : Patients with pre-existing diabetic retinopathy should be monitored closely, particularly during rapid improvement in glucose control Gallbladder disease : Semaglutide has been associated with an increased risk of cholelithiasis and cholecystitis Acute pancreatitis : Patients should seek immediate medical attention if they experience severe, persistent abdominal pain that may radiate to the back, often accompanied by vomiting Dehydration and acute kidney injury : The gastrointestinal effects may lead to dehydration, which can cause acute kidney injury
GLP-1 receptor agonists and SGLT-2 inhibitors are prescribed by some healthcare providers off-label for people with type 1 diabetes, but the ADA does not currently recommend them due to insufficient efficacy and safety data
1050 mg L-carnitine: L-carnitine ng vai tr l trung tm sn xut nng lng trong th hnh
Convenient Services: We provide Telemedicine services, which allow you to communicate with Dr
doi: 10.1007/s11892-022-01485-w 4 RochfordJJ
Wullschleger, S., Loewith, R